Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: IGC, NCH Awarded Nearly $80M for TCGA Support

This article replaces an earlier version that reported funding solely for IGC.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The International Genomics Consortium (IGC) in Phoenix, Ariz., and the Research Institute at Nationwide Children's Hospital (NCH) in Columbus, Ohio, have been awarded stimulus grants from the National Institutes of Health totaling nearly $80 million over five years to support the Cancer Genome Atlas Program.

IGC and NCH will manage biospecimens and samples for TCGA, as well as provide support services to the National Cancer Institute for researchers involved in TCGA.

The awards, which are funded in part by the American Recovery and Reinvestment Act, will be spread over five years and will provide IGC up to $37.5 million and NCH up to $41.4 million, if the option to extend is exercised after the base period of 18 months. For the base period, IGC will receive $12.3 million and NCH will receive $11.5 million.

IGC and NCH will provide support services for TCGA by establishing Biospecimen Core Resources (BCRs) for receiving tissue and data from the multiple Tissue Source Site networks. They will provide storage, quality control, processing, and shipping of analytes to genome characterization and sequencing centers for TCGA.

The biospecimen core centers' tasks include being an interface between TCGA and tissue source sites; ensuring and verifying that TCGA subject guidelines and protections have been followed; ensuring that all biospecimens meet standards; collecting clinical information about patients and their cancer samples; extracting and distributing DNA and RNA analytes from tissue samples and sending them to sequencing and characterization centers; and contributing to the leadership of the overall TCGA project.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.